2019 update of the EULAR recommendations for the management of SLE: don't forget chloroquine.
Published in Annals of the rheumatic diseases
SLE-DAS: ready for routine use?
Published in Annals of the rheumatic diseases
Chloroquine as alternative antimalarial in systemic lupus erythematosus. Response to '2019 update of the EULAR recommend...
Published in Annals of the rheumatic diseases
Response to: 'SLE-DAS: ready for routine use' by Mathew et al.
Published in Annals of the rheumatic diseases
Case report: a 10-year-old girl with primary hypoparathyroidism and systemic lupus erythematosus
...Published in Journal of Pediatric Endocrinology and Metabolism
Objectives Hypoparathyroidism is a rare disease in children that occurs as a result of autoimmune destruction of the parathyroid glands, a defect in parathyroid gland development or secondary to physical parathyroid gland disturbance. Typical symptoms of hypoparathyroidism present as hypocalcaemia and hyperphosphatemia due to decreased parathyroid ...
Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantib...
Published in Annals of the rheumatic diseases
Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus ...
...Published in Rheumatology (Oxford, England)
Blood transcriptomic IFN signature is a hallmark of SLE. The impaired health-related quality of life (HRQOL) observed in SLE is poorly related to disease activity. The aim of this study was to test how IFN signatures were associated with HRQOL in SLE patients. Among consecutive patients, blood transcriptomic profiles were analysed with a modular fr...
Elevated Circulating Interleukin-17 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis.
Published in Immunological investigations
Previous studies concerning the circulating interleukin-17 (IL-17) in systemic lupus erythematosus (SLE) were contradictory. To further precisely investigate circulating IL-17 in SLE and evaluate its influential factors by meta-analysis. EMBASE, PubMed and Cochrane Library were comprehensively searched to obtain studies on circulating IL-17 in SLE ...
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry.
...Published in Rheumatology (Oxford, England)
This article estimates the frequency of polyautoimmunity and associated factors in a large retrospective cohort of patients with SLE. RELESSER (Spanish Society of Rheumatology Lupus Registry) is a nationwide multicentre, hospital-based registry of SLE patients. This is a cross-sectional study. The main variable was polyautoimmunity, which was defin...
Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommen...
Published in Annals of the rheumatic diseases
